Tumor antigen-specific T helper cells in cancer immunity and immunotherapy

By K. Knutson, M. Disis. Cancer Immunology and Immunotherapy, 2005

675 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

pathfindR: An R Package for Comprehensive Identification of Enriched Pathways in Omics Data Through Active Subnetworks (2019, background): “…cancer pathway and related signaling pathways (El Sheikh et al., 2003; Shukla et al., 2007; Rodríguez-Berriguete et al., 2012), cancer immunity (Knutson and Disis, 2005; Zhao et al., 2014), Hippo signaling (Zhang et al., 2015), cell cycle (Balk and Knudsen, 2008), autophagy (Farrow et al.,…”
The polarization of immune cells in the tumour environment by TGFβ (2010, result): “However, later studies comparing the efficacy of T H 1 and T H 2 effector cell subsets in mediating antitumour immunity showed that both T H 1 and T H 2 cells increased the CTL-mediated antitumour response, although T H 1 cells secreting IFNγ seemed to be more effective by promoting APC activatio”
Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines (2008, background): “aspx?CdrID=42120">IFA ; used to stimulate the immune system) protected mice against a subsequent challenge with a live viru”